Company
Vividion Therapeutics, Inc.
We combine the power of chemoproteomics and covalent chemistry to forge life-changing connections between precision therapeutics and previously undrugged drivers of disease.
Also known as Vividion Therapeutics
- Status
- Operatingas of 2026-09-20
- Business model
- B2B
- Headquarters
- San Diego, CA, United States
- Legal name
- Vividion Therapeutics, Inc.
- vividion.com (opens in a new tab)
- LinkedIn (opens in a new tab)
- Press page (opens in a new tab)
- Careers (opens in a new tab)
Claim, correct or request removal
Record updated 28 September 2026
About
We are bringing more disease-causing targets within the reach of small molecule therapeutics to transform care for patients with devastating diseases not addressed by current therapies.
Funding snapshot
- Total raised
- $241MSEC form D sum, as of 2026-09-28Source (opens in a new tab)
- Latest round
- Round, $135M2021-02-18
Funding rounds
- Round, 2021
- $135M2021-02-18, SEC form D sold, 27 investors
- Round, 2019
- $82M2019-04-24, SEC form D sold, 20 investors
- Round, 2017
- $20.2M2017-01-03, SEC form D sold, 8 investors
- Round, 2016
- $3.5M2016-03-31, SEC form D sold, 1 investor
Loading relationship preview